These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18097337)

  • 1. [Molecular basis of diabetic retinopathy].
    Rusin P; Majsterek I
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():786-96. PubMed ID: 18097337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy.
    Amano S; Yamagishi S; Koda Y; Tsuneoka M; Soejima M; Okamoto T; Inagaki Y; Yamada K; Kimura H
    Med Hypotheses; 2003 Apr; 60(4):550-1. PubMed ID: 12615520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of sorbitol dehydrogenase -888G>C polymorphism with type 2 diabetic retinopathy in Caucasian-Brazilians.
    Ferreira FN; Crispim D; Canani LH; Gross JL; dos Santos KG
    Exp Eye Res; 2013 Oct; 115():140-3. PubMed ID: 23850972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in Sorbitol-Aldose Reductase (Polyol) Pathway Genes and Their Influence on Risk of Diabetic Retinopathy Among Han Chinese.
    Li W; Chen S; Mei Z; Zhao F; Xiang Y
    Med Sci Monit; 2019 Sep; 25():7073-7078. PubMed ID: 31539366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.
    Demaine A; Cross D; Millward A
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4064-8. PubMed ID: 11095596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes and diabetic retinopathy.
    Radha V; Rema M; Mohan V
    Indian J Ophthalmol; 2002 Mar; 50(1):5-11. PubMed ID: 12090088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three novel polymorphisms in the promoter region of the TIMP-3 gene are not associated with proliferative diabetic retinopathy in type 2 diabetes mellitus.
    Beránek M; Kanková K; Tschöplová S; Kolár P; Vácha J
    Curr Eye Res; 2003 Aug; 27(2):91-3. PubMed ID: 14632160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes.
    Kao YL; Donaghue K; Chan A; Knight J; Silink M
    Diabetes; 1999 Jun; 48(6):1338-40. PubMed ID: 10342825
    [No Abstract]   [Full Text] [Related]  

  • 10. Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy.
    Dyer KH; Silva PS; Sun JK
    Semin Ophthalmol; 2013; 28(5-6):347-54. PubMed ID: 24138044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes: response to Wang et al.
    P K Ng D; Chia KS; Koh D
    Diabetes Care; 2004 Jan; 27(1):289-90; author reply 290. PubMed ID: 14694018
    [No Abstract]   [Full Text] [Related]  

  • 12. [Polymorphism of aldose reductase gene and susceptibility to retinopathy and nephropathy in Caucasians with type 1 diabetes].
    Fanelli A; Hadjadj S; Gallois Y; Fumeron F; Betoule D; Grandchamp B; Marre M
    Arch Mal Coeur Vaiss; 2002; 95(7-8):701-8. PubMed ID: 12365083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis of diabetic retinopathy using functional protein sequences.
    Rao AA; Thota H; Gumpeny RS; Akula A; Changalasetty SB; Challa SR; Ravavarapu T; Akula SP; Divakar Ch; Srinivas K; Das UN
    Med Hypotheses; 2008; 70(1):148-55. PubMed ID: 17548166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymorphism of the dinucleotide repeat inside the aldose reductase gene in normal states and in patients with insulin-dependent diabetes mellitus with vascular complications].
    Chistiakov DA; Turakulov RI; Girashko NM; Demurov LM; Rachiba IuM; Kondrat'ev IaIu; Milen'kaia TM; Shestakova MV; Dedov II; Nosikov VV
    Mol Biol (Mosk); 1997; 31(5):778-83. PubMed ID: 9454059
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymorphisms of the aldose reductase locus (ALR2) and susceptibility to diabetic microvascular complications.
    Patel A; Ratanachaiyavong S; Millward BA; Demaine AG
    Adv Exp Med Biol; 1993; 328():325-32. PubMed ID: 8493909
    [No Abstract]   [Full Text] [Related]  

  • 16. The Relationship Between Aldose Reductase C106T Polymorphism and Diabetic Retinopathy: An Updated Meta-Analysis.
    Zhou M; Zhang P; Xu X; Sun X
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2279-89. PubMed ID: 25722213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor polymorphisms are involved in the late vascular complications in Type II diabetic patients.
    Bleda S; De Haro J; Varela C; Esparza L; Ferruelo A; Acin F
    Diab Vasc Dis Res; 2012 Jan; 9(1):68-74. PubMed ID: 22064697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes.
    Sivenius K; Niskanen L; Voutilainen-Kaunisto R; Laakso M; Uusitupa M
    Diabet Med; 2004 Dec; 21(12):1325-33. PubMed ID: 15569136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetics of diabetic complications: retinopathy].
    Taverna MJ
    Ann Endocrinol (Paris); 2004 Feb; 65(1 Suppl):S17-25. PubMed ID: 15163920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Retinopathy and Vascular Endothelial Growth Factor Gene Insertion/Deletion Polymorphism.
    Khan SZ; Ajmal N; Shaikh R
    Can J Diabetes; 2020 Apr; 44(3):287-291. PubMed ID: 31859041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.